| P50 | author | Vasee Moorthy | Q28955405 |
| | Johan Vekemans | Q28955487 |
| | David R. Nalin | Q5237914 |
| | Ranjan Ramasamy | Q7293102 |
| | Egeruan B Imoukhuede | Q37382456 |
| | Sonali Kochhar | Q55473907 |
| | Jan Bonhoeffer | Q56394692 |
| | Robert T. Chen | Q86371125 |
| | Mamodikoe Makhene | Q98710769 |
| | Ulrich Heininger | Q102068710 |
| | Ali Khamesipour | Q114412337 |
| | Rebecca Prevots | Q114412338 |
| P2093 | author name string | Virginia Wong | |
| | Khalequz Zaman | |
| | Soju Chang | |
| | Grace Aldrovandi | |
| | James D Heffelfinger | |
| | Rohini Fernandopulle | |
| | Elissa Malkin | |
| | Sarah Sellers | |
| | Novilia S Bachtiar | |
| | Karen L Goldenthal | |
| | Shah Hossain | |
| | Pam Wilson | |
| | Eng-Soon Chan | |
| | Brighton Collaboration Clinical Trial Protocol Working Group | |
| | Indira Jevaji | |
| | Kenneth B Walker | |
| P2860 | cites work | Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data | Q22251433 |
| | Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation | Q30540815 |
| | Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation | Q30540817 |
| | Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation | Q30890095 |
| | Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation | Q30890102 |
| | Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation | Q30890134 |
| | Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q31107779 |
| | Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q31107914 |
| | Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q31108130 |
| | Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data | Q31109981 |
| | Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q31112245 |
| | Robust take following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data | Q31114155 |
| | Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data | Q31114158 |
| | Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data | Q31114161 |
| | Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation | Q31114165 |
| | Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q31114324 |
| | Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data | Q31114573 |
| | Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q31114574 |
| | Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q31114967 |
| | Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data | Q31115845 |
| | Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data | Q31116047 |
| | Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations | Q33348739 |
| | A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q33379317 |
| | Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies | Q33389704 |
| | Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Q33763060 |
| | MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives | Q42605516 |
| | Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation | Q47836020 |
| | The development of standardized case definitions and guidelines for adverse events following immunization | Q80074697 |
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5602-5620 | |
| P577 | publication date | 2013-03-13 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Template protocol for clinical trials investigating vaccines--focus on safety elements | |
| P478 | volume | 31 | |